Founded in Basel,
built for the operating room.
Neurotech AG was founded in 2011 by Beat Alain, a biomedical engineer who spent four years building recording hardware for a neurosurgery department and grew tired of watching good electrodes fail at the tissue interface. The company is privately held and remains headquartered in Basel.
-->
Beat Alain
"We are not in the business of making the brain do what we want. We are in the business of listening carefully enough that the stimulation we deliver is the smallest one that works."
Beat Alain studied electrical engineering in Delft and worked as a research engineer in the neurosurgery department of a Swiss university hospital before founding Neurotech in a rented laboratory in Basel with three colleagues. He has served as chief executive since 2011 and holds 14 granted patents on electrode fabrication and closed-loop stimulation control.
He chairs the company's design review board and still signs off on every design change that touches the implanted hardware.
- 2011Founded in Basel. First recording prototype built for a single research site.
- 2014First patient implanted with an early closed-loop stimulator under a hospital exemption.
- 2018Long-term follow-up registry opened. Manufacturing moved to a dedicated site in Allschwil.
- 2021NT-100 CE-marked under EU MDR. Boston office opened for clinical affairs.
- 2025Series E closed at a CHF 3.1 bn valuation. Singapore office opened.
How we work
Engineers sit in on implant procedures. Clinical affairs sits in on design reviews. Nobody at Neurotech ships a change to an implanted device without a neurosurgeon in the room, and nobody publishes a number that our own biostatisticians have not checked against the raw data.
We keep manufacturing in Switzerland — arrays are assembled and inspected in Allschwil, twenty minutes from the office — because the tolerances that matter are the ones you can walk down the corridor and argue about.
Ownership and governance
Neurotech AG is a privately held Swiss stock corporation registered with the Commercial Register of the Canton of Basel-Stadt. The founder retains a controlling stake. The board includes representatives of our institutional investors and two independent members with clinical backgrounds.
An independent clinical advisory board of practising neurosurgeons and neurologists meets quarterly and has a standing mandate to halt any study on safety grounds.
-->
-->
-->
-->
-->
-->
-->
-->